PD-1 engagement by PD-L1 on cancer cells is known to interfere with TCR/CD28-dependent T cell signaling by blocking exhaustion-associated transcription factors, including the AP-1, NF-κB, and NFAT (34). This evidence concerns the gene NFKB1 and cancer.